| PATENT REGISTER | |||||||||||||||||||||
| Status | Lapsed | Patent No. | 2345668 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Application No. | 10014360.1 | Date of Filing | 28/04/2006 | ||||||||||||||||||
| Date Grant Published | 22/09/2021 | Application Published | 20/07/2011 | ||||||||||||||||||
| Title of Invention | SCLEROSTIN EPITOPES | ||||||||||||||||||||
| Priority |
|
||||||||||||||||||||
| Inventors |
Lu, Hsieng Sen Paszty, Christopher Robinson, Martyn Kim Henry, Alistair James Hoffmann, Kelly Sue Latham, John Lawson, Alastair Winkler, David Winters, Aaron George |
||||||||||||||||||||
| Current Proprietors |
UCB Pharma, S.A. Allée de la Recherche 60 1070 Bruxelles BELGIUM Amgen, Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 UNITED STATES OF AMERICA |
||||||||||||||||||||
| Earlier Application No. 10006930.1 | Granted | ||||||||||||||||||||
| Publication Language | English | ||||||||||||||||||||
| Translation Received Date | |||||||||||||||||||||
| 02/02/2023 | Patent lapsed due to non-payment of Patent Renewal Fee in respect of year 17. | ||||||||||||||||||||
